Home | BLOG | Catch the eye of biotech investors with PR that pops

Catch the eye of biotech investors with PR that pops
2:49

Catch the eye of biotech investors with PR that pops

Table of contents

By Jeff Rusack

Innovation is key In the world of biotech, but if word of your genius idea never leaves the lab, it might as well be science fiction. That’s where a biotech public relations team swoops in with its superhero cape—or lab coat (or both, both sound fun). Here’s how to make investors do a double take and get them excited to finance your breakthrough.

01. Find your DNA (distinct narrative angle):

Biotech can be complex, but your story shouldn’t be. Investors aren’t just buying a technology, they’re buying into a vision. Distill your narrative into a compelling, human-centered story, ideally one that showcases patient impact. 

Investors want data, but they need context. Don’t just dump charts and p-values in their lap. Pair numbers with stories that showcase the real-world impact of your technology. Did your gene therapy save a child’s life? Does your startup solve a pain point plaguing the industry? Investors are humans. The story catches their eye; the numbers catch their wallet.

Investors want data, but they need context. Don’t just dump charts and p-values in their lap. Pair numbers with stories that showcase the real-world impact of your technology.

02. Make headlines, not headaches:

The biotech world loves jargon almost as much as lab rats love cheese. But if your press release reads like a biochemistry textbook, you’ve already lost your audience. Instead, opt for clarity and an easy-to-understand story. 

Bad:

"Using our CRISPR-powered, AI-driven, synergistically optimized bioinformatics, we were able to drastically reduce the amount of cancerous cells within all eight lab-tested subjects.”

Better:

“Our research has made great strides in curing cancer.”  

03. Go viral (in a good way):

Want to catch an investor’s eye? Build buzz where they scroll. An engaging LinkedIn post, a snappy explainer video, or even a clever biotech meme can plant your brand in their brains. 

Your PR Pros know which outlets investors are reading (they have a pretty good sense of it anyway). Let them leverage your subject matter experts for thought leadership opportunities within these outlets, catching the eyes of investors even further. 

Want to catch an investor’s eye? Build buzz where they scroll. An engaging LinkedIn post, a snappy explainer video, or even a clever biotech meme can plant your brand in their brains.

 

04. Timing is everything:

Time your PR strategy with key milestones like clinical trial results, FDA approvals, or major funding rounds. 

A biotech PR specialist knows how to translate your groundbreaking science into headlines that pop. And just like in biotech, finding the right partner is all about chemistry. When the time is right to find your PR partner, consider these steps, and you’ll be well on your way to not just telling your story but having the right people listen.

 

Interested in submitting a guest blog? Learn more about our guest blog program!

Jeff Rusack
linkedin

As a 4X Emmy-nominated journalist, Jeff Rusack understands what it takes to tell a captivating story. From covering the immediate aftermath of tornadoes to shining a light on the remnants of Love Canal waste placed next to a neighborhood. Jeff’s coverage as a journalist almost always focused on the health of the people he was covering. Now, as a media relations manager with KNB Communications, he uses that knowledge of crafting stories and translates it to his healthcare clients. With his 10+ years of journalism experience, he amplifies the stories of companies helping people live longer, healthier lives, from the smallest of startups to the Fortune 10.

Search

  • There are no suggestions because the search field is empty.
KNBe in the know newsletter callouts-08 1

KNBe in the know

Subscribe to our newsletter for the latest news + trends in healthcare marketing + PR.

Quote

Biotech can be complex, but your story shouldn’t be. Investors aren’t just buying a technology, they’re buying into a vision. Distill your narrative into a compelling, human-centered story, ideally one that showcases patient impact. 

KNBe in the know

Subscribe to our newsletter for the latest news + trends in healthcare marketing + PR.